AEHR vs COHU: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
AEHR and COHU are similarly sized, but COHU trades noticeably cheaper on forward earnings (18.11x vs 35.31x): the market is paying up for AEHR's profile and pricing COHU more conservatively, or for faster growth. Which you prefer comes down to the drivers you believe, and whether adding either over-concentrates what you already own.
AEHR vs COHU: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | AEHR | COHU | What it tells you |
|---|---|---|---|
| Market cap | $1.95B | $2.03B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 35.31 | 18.11 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Beta | 3.33 | 1.61 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 32% of range | 40% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 8.74 | 2.57 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: COHU is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how AEHR and COHU affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AEHR and COHU share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AEHR and COHU exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Aehr Test Systems (AEHR) do?
Aehr Test Systems, headquartered in Fremont, California, designs and sells semiconductor test and burn-in equipment. Its FOX-P platform (FOX-XP and FOX-NP systems, plus WaferPak full-wafer contactors and DiePak carriers) performs wafer-level and singulated-die test, burn-in, and stabilization, processes that stress chips at elevated voltage and temperature to weed out early-life failures before the parts reach customers. Aehr also added ultra-high-power Sonoma systems for package-level burn-in of high-wattage devices. The company is one of the few suppliers offering both wafer-level and package-level burn-in across silicon carbide, gallium nitride, AI processors, silicon photonics, and flash memory.
What does Cohu (COHU) do?
Cohu, Inc. is a global supplier of test, automation, inspection, metrology, and software-analytics products and services to the semiconductor industry. Its equipment sits in the back end of chip manufacturing: test handlers (including thermal handlers like its Eclipse line), test contactors and interface products, inspection and metrology tools, and the software that runs and analyzes them. Roughly 40% of sales come from test and inspection systems, while about 60% is recurring revenue from interface products, spares, software, and services, which cushions the deep cyclicality of capital-equipment orders. Cohu serves customers across automotive, industrial, mobile, computing, and consumer chip end-markets, so its business tracks the broad health of the semiconductor cycle.
AEHR vs COHU: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- AEHR drivers: AI and data center diversification; Silicon photonics and optical interconnect.
- COHU drivers: AI and high-performance-computing ramp; Cyclical recovery in core end-markets.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Customer concentration is heavy: a small number of large semiconductor manufacturers drive most revenue, and the AI story leans on one lead hyperscale customer, so the loss or delay of a single program can swing results materially. For COHU, cohu is small and cyclical, so its orders and revenue are lumpy and swing hard with the semiconductor capital-equipment cycle and with automotive, industrial, and computing chip demand it does not control.
AEHR or COHU: which should you pick?
AEHR vs COHU: the full fundamentals
AEHR. Aehr swung back to a quarterly profit in fiscal Q4 2026, beating the consensus estimate, but the full fiscal year was still a loss on about $50 million of revenue. The roughly $2.1 billion market value prices in analyst expectations of about $136 million of revenue in fiscal 2027, and the stock has fallen about 34% over three months even after a 193% gain year to date. The next check is fiscal Q1 2027 results on November 2, 2026, where consensus sits near $26.6 million of revenue and $0.09 per share. All figures are approximate as of October 16, 2026.
COHU. As of mid-October 2026 Cohu trades around a $2.4 billion market cap on roughly $523 million of trailing revenue, a price-to-sales ratio near 4.6x, lower than in June because revenue grew faster than the share price over the summer. The trailing P/E is still negative and the forward P/E is about 28 on 2027 estimates, so the valuation rests on the recovery and AI/high-performance-computing ramp rather than current earnings. Third quarter results arrive October 28, 2026, with consensus at about $170 million of revenue and $0.35 of EPS.
Headline figures (approximate, October 2026): AEHR shows share price / market cap ~$64.93 (Oct 16, 2026), ~$2.1 billion, revenue (fy2026, ended may 2026) ~$50 million; fiscal Q4 ~$18.8 million, up ~34% year over year, net income FY2026 net loss ~$7.1 million (EPS ~-$0.23); fiscal Q4 profit ~$1.4 million, EPS $0.11 vs ~-$0.01 expected, margins (ttm) ~35% gross, ~-6% operating; COHU shows revenue (fy2025) ~$453 million (up ~13%), revenue (ttm) ~$523 million, q2 2026 revenue ~$149 million (up ~38% YoY), q2 2026 non-gaap eps ~$0.26 vs ~$0.14 consensus.
The bottom line: AEHR vs COHU
AEHR and COHU are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AEHR and COHU exposure against your real portfolio. It is not an investment adviser.
Wondering how AEHR or COHU fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Aehr Test Systems
Ask Walnut's AI anything about AEHR and see how it fits what you own.
FAQ
What is the difference between AEHR and COHU?
+
Aehr Test Systems, headquartered in Fremont, California, designs and sells semiconductor test and burn-in equipment. Cohu, Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is AEHR or COHU the better stock?
+
Neither is universally better; they suit different views and risk levels. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, AEHR or COHU?
+
On forward P/E (as of November 2026), AEHR trades at 35.31x and COHU at 18.11x, so COHU is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both AEHR and COHU?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of AEHR vs COHU?
+
AEHR: Customer concentration is heavy: a small number of large semiconductor manufacturers drive most revenue, and the AI story leans on one lead hyperscale customer, so the loss or delay of a single program can swing results materially. Competition concerns flared in October 2026 when Teradyne introduced its Titan HP platform and Aehr shares fell; Oppenheimer argued the two address different test stages (system-level test versus wafer-level burn-in), but the episode shows how sensitive the valuation is. The electric-vehicle and silicon carbide demand that powered prior years has softened, and management has stayed conservative about a SiC recovery. As a small-cap capital-equipment supplier, Aehr's orders are lumpy and tied to customers' capex cycles, which produced a fiscal 2026 net loss of about $7 million. The valuation is demanding: around 42 times trailing sales and about 47 times forward earnings, priced for the AI ramp to arrive roughly on schedule. The stock's 52-week range of about $18.70 to $147.40 shows how violently it can move in both directions. COHU: Cohu is small and cyclical, so its orders and revenue are lumpy and swing hard with the semiconductor capital-equipment cycle and with automotive, industrial, and computing chip demand it does not control. It is still reporting a trailing net loss (about $39 million over the last twelve months), so the stock carries a negative trailing price-to-earnings ratio and a forward multiple near 28 that depends on the recovery continuing. After more than doubling in 2026, the shares already price in much of that recovery, and insider sales, including about $3.3 million by CEO Luis Muller in September 2026, have drawn attention. It competes against far larger, better-capitalized test-industry leaders like Teradyne, which has been expanding its AI and memory test portfolio, and Advantest, and its high-performance-computing pipeline must convert from qualification to real production orders. Customer concentration, tariff and supply-chain costs, and geopolitical or export-control exposure in Asia add further risk, and the shares tend to be volatile.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell AEHR or COHU; figures are approximate and dated (as of November 2026). Verify current data before investing.